Patents by Inventor Jin Chai

Jin Chai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250369986
    Abstract: An application of a biomarker in preparing metabolic dysfunction-associated steatotic liver disease classification products is provided. The biomarker is any one or more of the following: a combination of liver protein biomarkers, a combination of serum protein biomarkers, a combination of serum lipid biomarkers, a combination of serum metabolite biomarkers, a combination of serum protein, lipid and metabolite biomarkers, a combination of urine protein biomarkers, a combination of urine metabolite biomarkers, and a combination of urine protein and metabolite biomarkers; and the metabolic dysfunction-associated steatotic liver disease is divided into a metabolically active type, a high-risk type of cirrhosis and a high-risk type of hepatocellular carcinoma. The combinations of biomarkers provided by the present disclosure have a good effect on the diagnosis of three MASLD molecular subtypes, which provides technical support for the classification and diagnosis of MASLD.
    Type: Application
    Filed: December 23, 2024
    Publication date: December 4, 2025
    Applicants: The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University, Chengdu Seventh People's Hospital
    Inventors: Jin CHAI, Zhongyong JIANG, Jingjing DING, Xiaoxun ZHANG
  • Patent number: 12330185
    Abstract: Disclosed are coating equipment and a coating method. The coating equipment comprises a coating die and a slurry parameter detector. The coating die comprises a first slot, a second slot, a first adjusting mechanism and a second adjusting mechanism. Through the arrangement of the first adjusting mechanism and the second adjusting mechanism, adjustment of the flow rate of slurry circulating in the first slot and the second slot can be realized, and parameters of coated slurry are detected by a slurry parameter detector, and are then compared with preset values, and comparison results are fed back to the first adjusting mechanism and the second adjusting mechanism for adjustment of the first adjusting piece and the second adjusting piece, so that automatic adjustment of double-layer die coating is realized, the debugging effectiveness is greatly improved, and the coating efficiency is further improved.
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: June 17, 2025
    Assignee: SHENZHEN MANST TECHNOLOGY CO., LTD.
    Inventors: Ning Li, Guishan Chen, Jin Chai, Zheng Liu
  • Publication number: 20250108402
    Abstract: Disclosed are coating equipment and a coating method. The coating equipment comprises a coating die and a slurry parameter detector. The coating die comprises a first slot, a second slot, a first adjusting mechanism and a second adjusting mechanism. Through the arrangement of the first adjusting mechanism and the second adjusting mechanism, adjustment of the flow rate of slurry circulating in the first slot and the second slot can be realized, and parameters of coated slurry are detected by a slurry parameter detector, and are then compared with preset values, and comparison results are fed back to the first adjusting mechanism and the second adjusting mechanism for adjustment of the first adjusting piece and the second adjusting piece, so that automatic adjustment of double-layer die coating is realized, the debugging effectiveness is greatly improved, and the coating efficiency is further improved.
    Type: Application
    Filed: February 24, 2022
    Publication date: April 3, 2025
    Applicant: SHENZHEN MANST TECHNOLOGY CO., LTD.
    Inventors: Ning LI, Guishan CHEN, Jin CHAI, Zheng LIU
  • Publication number: 20240159748
    Abstract: A molecular marker for diagnosing primary biliary cholangitis and a method for detecting same are provided. The anti-human multimer immunoglobulin receptor antibody is adopted as the primary biliary cholangitis diagnosis molecular marker so as to prepare the diagnosis reagent; the human multimer immunoglobulin receptor antibody is remarkably increased in serum of PBC AMA-M2 subtype positive and negative patients, which indicates that in the attack of PBC, the serum anti-human multimer immunoglobulin receptor antibody specifically targets human multimer immunoglobulin receptors on small and medium bile ducts in the liver, thereby causing damage to the small and medium bile ducts.
    Type: Application
    Filed: April 20, 2022
    Publication date: May 16, 2024
    Applicants: THE FIRST HOSPITAL AFFILIATED TO PLA ARMY MEDICAL UNIVERSITY, XIANGYA HOSPITAL CENTRAL SOUTH UNIVERSITY
    Inventors: Jin CHAI, Huiwen WANG, Qian LI, Qiong PAN, Min LIAO, Jintao XIAO, Yan GUO, Xiuru MAO, Shifang PENG, Xiaowei LIU, Cane TANG
  • Patent number: D878361
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: March 17, 2020
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Joshua Glenn Little, Vicki Huichi Chuang, Jin Chai